Bella I. Ayubova, S. Bondarenko, A. Smirnova, Y. Vlasova, N. Tsvetkov, M. Kanunnikov, D. Zhogolev, Yuliya Oleynikova, Elena Karyagina, R. Ilyasov, N. Zorina, Svetlana Belyaeva, Yulia Neredko, I. Samorodova, Yulia Chernih, Mikhail Lazarev, A. Kochergina, A. Nasredinova, I. Barkhatov, T. Gindina, I. Moiseev, A. Kulagin
{"title":"Gilteritinib作为FLT3突变的难治/复发急性髓性白血病成人患者异基因造血干细胞移植的桥梁","authors":"Bella I. Ayubova, S. Bondarenko, A. Smirnova, Y. Vlasova, N. Tsvetkov, M. Kanunnikov, D. Zhogolev, Yuliya Oleynikova, Elena Karyagina, R. Ilyasov, N. Zorina, Svetlana Belyaeva, Yulia Neredko, I. Samorodova, Yulia Chernih, Mikhail Lazarev, A. Kochergina, A. Nasredinova, I. Barkhatov, T. Gindina, I. Moiseev, A. Kulagin","doi":"10.18620/ctt-1866-8836-2022-11-3-4-60-69","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":39111,"journal":{"name":"Cellular Therapy and Transplantation","volume":"45 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Gilteritinib as a bridge to allogeneic hematopoietic stem cell transplantation in adult patients with refractory/relapsed acute myeloid leukemia with FLT3 mutations\",\"authors\":\"Bella I. Ayubova, S. Bondarenko, A. Smirnova, Y. Vlasova, N. Tsvetkov, M. Kanunnikov, D. Zhogolev, Yuliya Oleynikova, Elena Karyagina, R. Ilyasov, N. Zorina, Svetlana Belyaeva, Yulia Neredko, I. Samorodova, Yulia Chernih, Mikhail Lazarev, A. Kochergina, A. Nasredinova, I. Barkhatov, T. Gindina, I. Moiseev, A. Kulagin\",\"doi\":\"10.18620/ctt-1866-8836-2022-11-3-4-60-69\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":39111,\"journal\":{\"name\":\"Cellular Therapy and Transplantation\",\"volume\":\"45 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cellular Therapy and Transplantation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18620/ctt-1866-8836-2022-11-3-4-60-69\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cellular Therapy and Transplantation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18620/ctt-1866-8836-2022-11-3-4-60-69","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Gilteritinib as a bridge to allogeneic hematopoietic stem cell transplantation in adult patients with refractory/relapsed acute myeloid leukemia with FLT3 mutations